Masked cancer drug trains immune system to kill tumors while sparing healthy tissues

Many cancer treatments are notoriously savage on the body. Drugs often attack both healthy cells and tumor cells, causing a plethora of side effects. Immunotherapies that help the immune system recognize and attack cancer cells are no different. Though they have prolonged the lives of countless patients, they work in only a subset of patients. One study found that fewer than 30% of breast cancer patients respond to one of the most common forms of immunotherapy.

But what if drugs could be engineered to attack only tumor cells and spare the rest of the body? To that end, my colleagues and I at the University of Chicago’s Pritzker School of Molecular Engineering have designed a method to keep one promising cancer drug from wreaking havoc by “masking” it until it reaches a tumor....

Popular posts from this blog

History Archive: Communist Party of India's resolution on Pakistan and National Unity, September 1942

The Almond Trees by Albert Camus (1940)

Pakistan's First Law & Labour Minister, Jogendra Nath Mandal's Resignation Letter, October 1950

Ben Marks - The Mao Mango Cult of 1968 and the Rise of China's Working Class

The Manifesto of the Anti-Fascist Intellectuals: Written by Benedetto Croce (1925)

Muslim girl meets Hindu boy. How our forbidden love blossomed in Canada

Did Stalin poison Lenin?